12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
Clinical trial NCT03777059 · COMPLETED
Trial details
- NCT number
- NCT03777059
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-14
- Primary completion
- 2020-06-19
- Enrollment
- 910
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.